Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

ClinicalTrials.gov ID: NCT06007183

Public ClinicalTrials.gov record NCT06007183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (PXVX0317) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen

Study identification

NCT ID
NCT06007183
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bavarian Nordic
Industry
Enrollment
800 participants

Conditions and interventions

Interventions

  • CHIKV VLP vaccine booster Biological
  • Placebo booster Biological

Biological

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2023
Primary completion
Mar 31, 2028
Completion
Jul 31, 2028
Last update posted
Apr 2, 2025

2023 – 2028

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Alliance for Multispecialty Research, LLC Mobile Alabama 36608
Alliance for Multispecialty Research, LLC Tempe Arizona 85281
Optimal Research, LLC Melbourne Florida 32934
Suncoast Research Associates, LLC Miami Florida 33173
Synexus Clinical Research US, Inc. Chicago Illinois 60602
Optimal Research, LLC Peoria Illinois 61614
Alliance for Multispecialty Research, LLC Newton Kansas 67114
Alliance for Multispecialty Research, LLC Wichita Kansas 67207
Alliance for Multispecialty Research, LLC Lexington Kentucky 40509
Alliance for Multispecialty Research, LLC Kansas City Missouri 64114
Wr-Crcn, Llc Las Vegas Nevada 89106
Alliance for Multispecialty Research, LLC Las Vegas Nevada 89119
Rochester Clinical Research, LLC Rochester New York 14609
M3 Wake Research Inc. Raleigh North Carolina 27612
Velocity Clinical Research, Cleveland Cleveland Ohio 44122
Lynn Institute of Norman Norman Oklahoma 73072
Velocity Clinical Research, Medford Medford Oregon 97504
Velocity Clinical Research, Providence East Greenwich Rhode Island 02818
Velocity Clinical Research, Austin Cedar Park Texas 78613
DM Clinical Research Houston Texas 77081
BFHC Research, LLC San Antonio Texas 78249
DM Clinical Research Tomball Texas 77375
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Alliance for Multispecialty Research, LLC Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06007183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06007183 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →